Pathway,both,humann2,mpro,num_Ecs,sample
Acarbose and validamycin biosynthesis,2.0,0.0,0.0,14,501_cecq_y_hk
Aflatoxin biosynthesis,1.0,0.0,0.0,13,501_cecq_y_hk
"Alanine, aspartate and glutamate metabolism",13.0,3.0,8.0,50,501_cecq_y_hk
Amino sugar and nucleotide sugar metabolism,19.0,0.0,14.0,119,501_cecq_y_hk
Aminoacyl-tRNA biosynthesis,22.0,0.0,2.0,31,501_cecq_y_hk
Aminobenzoate degradation,1.0,1.0,3.0,51,501_cecq_y_hk
Arginine and proline metabolism,12.0,3.0,7.0,86,501_cecq_y_hk
Arginine biosynthesis,9.0,2.0,6.0,28,501_cecq_y_hk
Ascorbate and aldarate metabolism,4.0,1.0,3.0,46,501_cecq_y_hk
Atrazine degradation,1.0,0.0,0.0,10,501_cecq_y_hk
Benzoate degradation,2.0,0.0,5.0,69,501_cecq_y_hk
Biosynthesis of ansamycins,1.0,0.0,0.0,4,501_cecq_y_hk
Biosynthesis of antibiotics,98.0,12.0,38.0,496,501_cecq_y_hk
Biosynthesis of secondary metabolites,142.0,17.0,56.0,778,501_cecq_y_hk
Biosynthesis of siderophore group nonribosomal peptides,1.0,1.0,1.0,6,501_cecq_y_hk
Biosynthesis of unsaturated fatty acids,0.0,0.0,4.0,16,501_cecq_y_hk
Biosynthesis of vancomycin group antibiotics,1.0,0.0,0.0,10,501_cecq_y_hk
Biotin metabolism,7.0,1.0,3.0,20,501_cecq_y_hk
Butanoate metabolism,6.0,3.0,7.0,55,501_cecq_y_hk
C5-Branched dibasic acid metabolism,3.0,0.0,4.0,22,501_cecq_y_hk
Caprolactam degradation,0.0,0.0,2.0,21,501_cecq_y_hk
Carbapenem biosynthesis,2.0,0.0,0.0,5,501_cecq_y_hk
Carbon fixation in photosynthetic organisms,11.0,0.0,5.0,25,501_cecq_y_hk
Carbon fixation pathways in prokaryotes,10.0,0.0,16.0,50,501_cecq_y_hk
Chloroalkane and chloroalkene degradation,1.0,0.0,1.0,17,501_cecq_y_hk
Citrate cycle (TCA cycle),7.0,1.0,9.0,26,501_cecq_y_hk
Cyanoamino acid metabolism,2.0,0.0,3.0,30,501_cecq_y_hk
Cysteine and methionine metabolism,21.0,3.0,5.0,76,501_cecq_y_hk
D-Alanine metabolism,2.0,0.0,0.0,6,501_cecq_y_hk
D-Glutamine and D-glutamate metabolism,4.0,0.0,0.0,12,501_cecq_y_hk
Dioxin degradation,2.0,0.0,0.0,13,501_cecq_y_hk
Drug metabolism - cytochrome P450,2.0,0.0,0.0,8,501_cecq_y_hk
Drug metabolism - other enzymes,11.0,0.0,1.0,25,501_cecq_y_hk
Ethylbenzene degradation,0.0,0.0,1.0,6,501_cecq_y_hk
Fatty acid biosynthesis,7.0,1.0,1.0,17,501_cecq_y_hk
Fatty acid degradation,2.0,0.0,7.0,29,501_cecq_y_hk
Fatty acid elongation,0.0,0.0,3.0,13,501_cecq_y_hk
Folate biosynthesis,8.0,0.0,9.0,51,501_cecq_y_hk
Fructose and mannose metabolism,16.0,0.0,8.0,75,501_cecq_y_hk
Galactose metabolism,12.0,2.0,6.0,48,501_cecq_y_hk
Geraniol degradation,0.0,0.0,3.0,10,501_cecq_y_hk
Glucosinolate biosynthesis,1.0,0.0,0.0,15,501_cecq_y_hk
Glutathione metabolism,10.0,1.0,4.0,39,501_cecq_y_hk
Glycerolipid metabolism,1.0,2.0,5.0,40,501_cecq_y_hk
Glycerophospholipid metabolism,7.0,1.0,4.0,61,501_cecq_y_hk
"Glycine, serine and threonine metabolism",18.0,4.0,6.0,68,501_cecq_y_hk
Glycolysis / Gluconeogenesis,20.0,1.0,5.0,48,501_cecq_y_hk
Glycosaminoglycan degradation,2.0,0.0,0.0,15,501_cecq_y_hk
Glycosphingolipid biosynthesis - ganglio series,2.0,0.0,0.0,8,501_cecq_y_hk
Glycosphingolipid biosynthesis - globo and isoglobo series,1.0,0.0,2.0,13,501_cecq_y_hk
Glyoxylate and dicarboxylate metabolism,9.0,4.0,10.0,73,501_cecq_y_hk
Histidine metabolism,9.0,0.0,4.0,38,501_cecq_y_hk
Human cytomegalovirus infection,1.0,0.0,0.0,2,501_cecq_y_hk
Human papillomavirus infection,1.0,0.0,0.0,2,501_cecq_y_hk
Inositol phosphate metabolism,2.0,1.0,6.0,48,501_cecq_y_hk
Insect hormone biosynthesis,0.0,0.0,1.0,9,501_cecq_y_hk
Isoquinoline alkaloid biosynthesis,0.0,0.0,2.0,57,501_cecq_y_hk
Limonene and pinene degradation,0.0,0.0,2.0,16,501_cecq_y_hk
Lipoic acid metabolism,2.0,0.0,0.0,3,501_cecq_y_hk
Lipopolysaccharide biosynthesis,10.0,1.0,5.0,27,501_cecq_y_hk
Lysine biosynthesis,11.0,2.0,2.0,28,501_cecq_y_hk
Lysine degradation,0.0,0.0,8.0,53,501_cecq_y_hk
Metabolic pathways,318.0,35.0,157.0,1650,501_cecq_y_hk
Metabolism of xenobiotics by cytochrome P450,2.0,0.0,0.0,10,501_cecq_y_hk
Methane metabolism,12.0,1.0,6.0,87,501_cecq_y_hk
Microbial metabolism in diverse environments,92.0,13.0,51.0,668,501_cecq_y_hk
Monobactam biosynthesis,3.0,2.0,0.0,10,501_cecq_y_hk
N-Glycan biosynthesis,0.0,0.0,1.0,34,501_cecq_y_hk
Naphthalene degradation,1.0,0.0,0.0,9,501_cecq_y_hk
"Neomycin, kanamycin and gentamicin biosynthesis",0.0,0.0,1.0,28,501_cecq_y_hk
Nicotinate and nicotinamide metabolism,8.0,2.0,5.0,59,501_cecq_y_hk
Nitrogen metabolism,5.0,0.0,5.0,37,501_cecq_y_hk
Nitrotoluene degradation,1.0,0.0,0.0,7,501_cecq_y_hk
Novobiocin biosynthesis,1.0,0.0,1.0,16,501_cecq_y_hk
One carbon pool by folate,10.0,0.0,6.0,24,501_cecq_y_hk
Other glycan degradation,2.0,0.0,1.0,9,501_cecq_y_hk
Oxidative phosphorylation,4.0,0.0,4.0,11,501_cecq_y_hk
PI3K-Akt signaling pathway,1.0,0.0,0.0,2,501_cecq_y_hk
Pantothenate and CoA biosynthesis,13.0,0.0,1.0,31,501_cecq_y_hk
Penicillin and cephalosporin biosynthesis,1.0,0.0,0.0,14,501_cecq_y_hk
Pentose and glucuronate interconversions,12.0,3.0,3.0,67,501_cecq_y_hk
Pentose phosphate pathway,17.0,1.0,5.0,55,501_cecq_y_hk
Peptidoglycan biosynthesis,11.0,0.0,1.0,19,501_cecq_y_hk
Phenazine biosynthesis,1.0,0.0,0.0,13,501_cecq_y_hk
Phenylalanine metabolism,8.0,2.0,5.0,67,501_cecq_y_hk
"Phenylalanine, tyrosine and tryptophan biosynthesis",12.0,1.0,3.0,39,501_cecq_y_hk
Phenylpropanoid biosynthesis,0.0,0.0,2.0,30,501_cecq_y_hk
Phosphatidylinositol signaling system,1.0,0.0,2.0,29,501_cecq_y_hk
Phosphonate and phosphinate metabolism,3.0,1.0,0.0,29,501_cecq_y_hk
Photosynthesis,1.0,0.0,1.0,3,501_cecq_y_hk
Polyketide sugar unit biosynthesis,3.0,0.0,1.0,27,501_cecq_y_hk
Porphyrin and chlorophyll metabolism,13.0,1.0,10.0,106,501_cecq_y_hk
Primary bile acid biosynthesis,0.0,0.0,1.0,19,501_cecq_y_hk
Propanoate metabolism,7.0,5.0,6.0,55,501_cecq_y_hk
Purine metabolism,40.0,2.0,7.0,110,501_cecq_y_hk
Pyrimidine metabolism,27.0,0.0,4.0,65,501_cecq_y_hk
Pyruvate metabolism,15.0,3.0,14.0,67,501_cecq_y_hk
Relaxin signaling pathway,1.0,0.0,0.0,1,501_cecq_y_hk
Retinol metabolism,1.0,0.0,0.0,14,501_cecq_y_hk
Riboflavin metabolism,3.0,2.0,6.0,28,501_cecq_y_hk
Secondary bile acid biosynthesis,0.0,1.0,0.0,14,501_cecq_y_hk
Selenocompound metabolism,5.0,1.0,4.0,18,501_cecq_y_hk
Sphingolipid metabolism,1.0,0.0,2.0,27,501_cecq_y_hk
Starch and sucrose metabolism,11.0,3.0,10.0,76,501_cecq_y_hk
Streptomycin biosynthesis,4.0,0.0,5.0,18,501_cecq_y_hk
Styrene degradation,1.0,0.0,1.0,19,501_cecq_y_hk
Sulfur metabolism,9.0,1.0,2.0,50,501_cecq_y_hk
Synthesis and degradation of ketone bodies,0.0,0.0,2.0,6,501_cecq_y_hk
T cell receptor signaling pathway,1.0,0.0,0.0,2,501_cecq_y_hk
Taurine and hypotaurine metabolism,3.0,0.0,3.0,19,501_cecq_y_hk
Terpenoid backbone biosynthesis,7.0,0.0,4.0,51,501_cecq_y_hk
Th1 and Th2 cell differentiation,1.0,0.0,0.0,1,501_cecq_y_hk
Thermogenesis,1.0,0.0,0.0,1,501_cecq_y_hk
Thiamine metabolism,10.0,1.0,1.0,26,501_cecq_y_hk
Toluene degradation,0.0,0.0,2.0,26,501_cecq_y_hk
"Tropane, piperidine and pyridine alkaloid biosynthesis",1.0,0.0,4.0,27,501_cecq_y_hk
Tryptophan metabolism,1.0,0.0,10.0,60,501_cecq_y_hk
Tyrosine metabolism,2.0,1.0,2.0,64,501_cecq_y_hk
Ubiquinone and other terpenoid-quinone biosynthesis,7.0,4.0,2.0,40,501_cecq_y_hk
"Valine, leucine and isoleucine biosynthesis",8.0,0.0,1.0,14,501_cecq_y_hk
"Valine, leucine and isoleucine degradation",1.0,1.0,10.0,36,501_cecq_y_hk
Various types of N-glycan biosynthesis,1.0,0.0,1.0,23,501_cecq_y_hk
Vitamin B6 metabolism,6.0,1.0,1.0,26,501_cecq_y_hk
Xylene degradation,2.0,0.0,0.0,21,501_cecq_y_hk
Zeatin biosynthesis,1.0,0.0,0.0,10,501_cecq_y_hk
alpha-Linolenic acid metabolism,1.0,0.0,2.0,12,501_cecq_y_hk
beta-Alanine metabolism,5.0,0.0,4.0,37,501_cecq_y_hk
beta-Lactam resistance,1.0,0.0,0.0,1,501_cecq_y_hk
mTOR signaling pathway,1.0,0.0,0.0,5,501_cecq_y_hk
